Pharmacological inhibition and genetic deletion of PCSK9: in vitro and in vivo studies on smooth muscle cell aortic calcification

Project
Pharmacological inhibition and genetic deletion of PCSK9: in vitro and in vivo studies on smooth muscle cell aortic calcification

Overview

Contributors

CORSINI ALBERTO   Scientific Manager  

Departments involved

Type

PRIN2022 - PRIN bando 2022

Funder

MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
External Organization Funding Organization

Date/time interval

October 16, 2023 - February 28, 2026

Project duration

28 months

Publications

Outputs (3)

Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors 
THE EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
WILEY
2025
Academic Article
Open Access
Altmetric is disabled. Enable it on "Use of Cookies"
Therapeutic PCSK9 targeting: Inside versus outside the.hepatocyte? 
PHARMACOLOGY & THERAPEUTICS
ELSEVIER
2025
Academic Article
Open Access
Altmetric is disabled. Enable it on "Use of Cookies"
Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action? 
ATHEROSCLEROSIS PLUS
ELSEVIER
2024
Academic Article
Open Access
Altmetric is disabled. Enable it on "Use of Cookies"